NOTCH1 and acute lymphoblastic leukemia: These mechanisms have been confirmed in human NOTCH1 mutated T-ALL Jurkat cells, where treatment with OSI-027, by inhibiting mTORC1-mediated 4E-BP1 phosphorylation, led to the decreased expression of c-Myc and subsequent upregulation of PUMA [154].